Ericka P. Simpson, M.D.
Director, Neurology Residency Program and
Associate Professor of Neurology
Houston, Texas 77030
Dr Simpson is Co-director, MDA Neuromuscular Clinics and Director, ALS Clinical Research Division. Her clinical focus includes a wide range of neuromuscular disorders: Muscular Dystrophy, Myasthenia Gravis, Neuropathy, ALS, Inflammatory myopathy, mitochondrial and metabolic myopathy.
She is also education director of the Neurology residency program and Neuromuscular Medicine Fellowship Program. She has served as an writer for the American Academy of Neurology’s Residency In Service Training Examination Committee, and as an examiner for the American Board of Psychiatry and Neurology Part II Certification Board Exam. She currently serves as co-chair for the ALS/MND session of the American Academy of Neurology (AAN) and Sub-committee Chair of the Neurology Self-Assessment Examination (Annual Meeting Edition 2013) .
Characterize the peripheral immune inflammatory response in ALS and other neurodegenerative diseases and identify the potential markers that may reflect disease activity and progression. Translational research that leads to the identification and development of effective therapies aimed at positively altering the natural history of these diseases.
M.D. - University of Texas at Houston Medical School
American Board of Psychiatry and Neurology-recertified